Market Place
Sourcing Support
Medicure to Present Q3 2024 Financial Results, Resignation
18 Nov 2024 //
ACCESSWIRE
Medicure Settles Product Development and Supply Contracts
25 Oct 2024 //
ACCESSWIRE
Poly Medicure posts Q1 FY25 consolidated PAT at Rs. 74.03 Cr
23 Jul 2024 //
INDIANPHARMAPOST
Medicure: Q1 2024 Financials, AGM Director Election Results Reported
28 May 2024 //
ACCESSWIRE
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
23 Apr 2024 //
ACCESSWIRE
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
08 Apr 2024 //
ACCESSWIRE
Medicure Receives Approval to Enroll Patients for Treatment of Rare Disease
23 Nov 2023 //
ACCESSWIRE
Medicure Reiterates to Providing Exceptional Access to its Branded Pitavastatin
29 Aug 2023 //
ACCESSWIRE
Medicure Reports Financial Results For Quarter Ended June 30, 2023
28 Jul 2023 //
ACCESSWIRE
Medicure to Present Financial Results on July 31 for Quarter Ended June 30, 2023
24 Jul 2023 //
ACCESSWIRE
Medicure Reports Financial Results for Quarter Ended March 31, 2023
26 May 2023 //
ACCESSWIRE
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2022
06 Apr 2023 //
ACCESSWIRE
Medicure To Present Financial Results for Quarter Ended December 31, 2022
05 Apr 2023 //
ACCESSWIRE
MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS
01 Feb 2023 //
PR NEWSWIRE
Medicure Reports Financial Results For Quarter Ended September 30, 2022
24 Nov 2022 //
FIRSTWORDPHARMA
Medicure To Present Financial Results On November 25, 2022 Call
17 Nov 2022 //
PRNEWSWIRE
Medicure Reports Financial Results For Quarter Ended JUNE 30, 2022
24 Aug 2022 //
PRNEWSWIRE
MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL
17 Aug 2022 //
PRNEWSWIRE
Medicure Announces Results Of 2022 AGM
20 Jun 2022 //
PRNEWSWIRE
Medicure Reports Q1 Financial Results; Appoints New CFO
30 May 2022 //
PRNEWSWIRE
Medicure Reports Financial Results For Quarter And Year Ended December 31, 2021
27 Apr 2022 //
PRNEWSWIRE
Medicure Announces Resignation Of Chief Financial Officer And Succession Plan
23 Mar 2022 //
PRNEWSWIRE
Medicure Reports Financial Results for Quarter Ended September 30, 2021
22 Nov 2021 //
PRNEWSWIRE
Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN®
04 Nov 2021 //
PRNEWSWIRE
Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021
27 Aug 2021 //
PRNEWSWIRE
Medicure Announces Appointment of David Gurvey as Chief Financial Officer
26 Jun 2021 //
PR NEWSWIRE
Medicure Announces Appointment of David Gurvey as Chief Financial Officer
26 Jun 2021 //
PR NEWSWIRE
Medicure to Participate in Renmark`s Virtual Non-Deal Roadshow Series on March 9
08 Mar 2021 //
PRNEWSWIRE
Medicure Announces Early Completion of Enrollment for Ispasm
28 Jan 2021 //
PRNEWSWIRE
MEDICURE ANNOUNCES EARLY COMPLETION OF ENROLLMENT FOR ISPASM, A PHASE 1/2A
28 Jan 2021 //
MEDICURE
Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for of Seizures
07 Jan 2021 //
PRNEWSWIRE
Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment
07 Jan 2021 //
PRNEWSWIRE
Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug
17 Dec 2020 //
PRNEWSWIRE
Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug
17 Dec 2020 //
BIOSPACE
Medicure announces an agreement with Reliance Life for the marketing rights
05 Oct 2020 //
PRNEWSWIRE
Medicure announces an agreement with Reliance Life Sciences for marketing rights
05 Oct 2020 //
PRNEWSWIRE
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications
24 Aug 2020 //
PRNEWSWIRE
Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER
29 Jun 2020 //
PRNEWSWIRE
Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™
25 Jun 2020 //
PRNEWSWIRE
Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™
25 Jun 2020 //
PRNEWSWIRE
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT
15 Jun 2020 //
PRNEWSWIRE
Medicure Files Patent Infringement Action
05 Dec 2019 //
PR NEWSWIRE
Medicure Announces Settlement of Holdback Dispute from Apicore Sale
05 Dec 2019 //
PR NEWSWIRE
Medicure Announces Preferred Pricing Agreement for Zypitamag™
04 Oct 2019 //
PR NEWSWIRE
Cadila inks pact to sell rights of cholesterol lowering drug in US to Medicure
01 Oct 2019 //
MONEYCONTROL
Medicure Files Patent Infringement Action
16 Nov 2018 //
PR NEWSWIRE
Medicure Announces Normal Course Issuer Bid
17 May 2018 //
PRNEWSWIRE
Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.
01 May 2018 //
PR NEWSWIRE
Medicure Announces Further Up-Date on PREXXARTAN®
28 Mar 2018 //
PR NEWSWIRE
Medicure Acquires Exclusive License to Sell & Market Branded Cardio Drug U.S.
14 Dec 2017 //
PR NEWSWIRE
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S.
31 Oct 2017 //
PR NEWSWIRE
Medicure Announces Filing of ANDA in Collaboration with Apicore
14 Dec 2016 //
PR NEWSWIRE
Medicure to acquire controlling stake in Apicore
21 Nov 2016 //
PHARMABIZ
Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
10 Sep 2015 //
PR NEWS WIRE
